Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23343427 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs
Condition: Bronchitis, Chronic
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)

Indicates status has not been verified in more than two years